Next Article in Journal
Identification of Two Novel Anti-Fibrotic Benzopyran Compounds Produced by Engineered Strains Derived from Streptomyces xiamenensis M1-94P that Originated from Deep-Sea Sediments
Next Article in Special Issue
Trypanocidal Activity of Marine Natural Products
Previous Article in Journal
Biosynthesis of Polyunsaturated Fatty Acids in Marine Invertebrates: Recent Advances in Molecular Mechanisms
Previous Article in Special Issue
Synthesis of Marine α-Methoxylated Fatty Acid Analogs that Effectively Inhibit the Topoisomerase IB from Leishmania donovani with a Mechanism Different from that of Camptothecin
Open AccessArticle

Assessment of Dual Life Stage Antiplasmodial Activity of British Seaweeds

1
Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University of London, London WC1N 1AX, UK
2
Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel CH-4002, Switzerland
3
University of Basel, Petersplatz 1, Basel CH-4003, Switzerland
4
Instituto de Medicina Molecular, Universidade de Lisboa, Lisbon 1649-028, Portugal
5
School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2DT, UK
6
School of Chemistry, National University of Ireland, Galway, Ireland
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Mar. Drugs 2013, 11(10), 4019-4034; https://doi.org/10.3390/md11104019
Received: 13 August 2013 / Revised: 8 October 2013 / Accepted: 11 October 2013 / Published: 22 October 2013
(This article belongs to the Special Issue Antiprotozoal Marine Natural Products)
Terrestrial plants have proven to be a prolific producer of clinically effective antimalarial drugs, but the antimalarial potential of seaweeds has been little explored. The main aim of this study was to assess the in vitro chemotherapeutical and prophylactic potential of the extracts of twenty-three seaweeds collected from the south coast of England against blood stage (BS) and liver stage (LS) Plasmodium parasites. The majority (14) of the extracts were active against BS of P. falciparum, with brown seaweeds Cystoseira tamariscifolia, C. baccata and the green seaweed Ulva lactuca being the most active (IC50s around 3 μg/mL). The extracts generally had high selectivity indices (>10). Eight seaweed extracts inhibited the growth of LS parasites of P. berghei without any obvious effect on the viability of the human hepatoma (Huh7) cells, and the highest potential was exerted by U. lactuca and red seaweeds Ceramium virgatum and Halopitys incurvus (IC50 values 14.9 to 28.8 μg/mL). The LS-active extracts inhibited one or more key enzymes of the malarial type-II fatty acid biosynthesis (FAS-II) pathway, a drug target specific for LS. Except for the red seaweed Halopitys incurvus, all LS-active extracts showed dual activity versus both malarial intracellular stage parasites. This is the first report of LS antiplasmodial activity and dual stage inhibitory potential of seaweeds. View Full-Text
Keywords: seaweed; marine alga; malaria; Plasmodium; malaria prophylaxis; fatty acid biosynthesis; liver stage; blood stage seaweed; marine alga; malaria; Plasmodium; malaria prophylaxis; fatty acid biosynthesis; liver stage; blood stage
Show Figures

Graphical abstract

MDPI and ACS Style

Spavieri, J.; Allmendinger, A.; Kaiser, M.; Itoe, M.A.; Blunden, G.; Mota, M.M.; Tasdemir, D. Assessment of Dual Life Stage Antiplasmodial Activity of British Seaweeds. Mar. Drugs 2013, 11, 4019-4034.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop